FDANonrulemakingFDA-2023-D-3031

Who commented on this docket

Alternative Tools: Assessing Drug Manufacturing Facilities Identified in Pending Applications; Draft Guidance for Industry; Availability

1 organizations filed 1 public comment on Alternative Tools: Assessing Drug Manufacturing Facilities Identified in Pending Applications; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 980d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 980d ago

Abstract

OPEN

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.